Zoetis Inc.
Health
Performance
7.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

Zoetis Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

01.07.2026
Slight cracks showing. Still strong – just not flawless anymore.
08.05.2026
On shaky ground. Struggling to find a clear direction.
08.05.2026
Trouble brewing. Volatility and pressure rising.
ZTS
Low-poly 3D Zoetis (ZTS) stock icon with a stylized paw print, symbolizing industrials.
76.19
-0.48%
7.5
Sell
Buy
Zoetis Inc.

Zoetis Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Zoetis Inc. do? Business model and key facts

Get the full picture of Zoetis Inc.: what it builds, where it operates, and how it makes money.

Zoetis Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees (FY): 14500

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

shop
Company facts
Kristin C. Peck
CEO
14500
Employees worldwide
shop
Performance
-48.3%
Last 12 months
-61.93%
Last 5 years
shop
Growth
$9.47B
Revenue year
$2.67B
Net income
shop
Valuation
$32.10B
Market Cap
20.87
Price/Earnings Ratio

Stocks related to Zoetis Inc.

Selected based on industry alignment and relative market positioning.

BAYN.DE
Bayer Aktiengesellschaft
47.36
+0.11%
5.1
Sell
Buy
Bayer Aktiengesellschaft
GSK
Low-poly 3D GSK (GSK) stock icon with a stylized pill capsule, symbolizing healthcare and biotech.
50.04
-3.32%
2.8
Sell
Buy
GSK plc
SNY
Low-poly 3D Sanofi (SNY) stock icon with a stylized pill capsule, symbolizing healthcare and biotech.
43.98
-1.52%
2.2
Sell
Buy
Sanofi
BIIB
Biogen Inc.
199.95
-2.93%
2.4
Sell
Buy
Biogen Inc.
GRFS
Grifols, S.A.
7.61
+4.68%
5.4
Sell
Buy
Grifols, S.A.

Events and news impacting Zoetis Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Zoetis Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.